UCHealth is slicing the cost of a cancer drug after acknowledging it had been overcharging patients and insurance companies for years. The move, following a Coloradoan investigation into the health ...

The drug goserelin – commonly known as Zoladex – has been a quietly crucial medicine in Australia for decades. This prescription medicine is used to suppress sex hormones, and is a key medication for ...

The cost of Zoladex can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Zoladex. As with all medications, ...

AstraZeneca announced that Zoladex, a drug used to reduce sex hormone levels, would continue to be made available to patients. It had been scheduled to be pulled from the Pharmaceutical Benefits ...

DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today that The National Comprehensive Cancer Network® (NCCN) Breast Cancer Panel included both goserelin 3.6 mg every 4 weeks and ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 3.6 mg contains the active ingredient goserelin acetate.

Women with breast cancer or endometriosis will have free and continued access to a life-saving drug, after a pharmaceutical giant bowed to widespread pressure and committed to supplying the medication ...

AstraZeneca's cancer drug Zoladex brought in more than $816 million worldwide last year, but only $69 million of that in the U.S. AstraZeneca is offloading yet another set of drug rights to streamline ...

Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, ...

Add Yahoo as a preferred source to see more of our stories on Google. The drug goserelin – commonly known as Zoladex – has been a quietly crucial medicine in Australia for decades. This prescription ...

February 25, 2009 — In premenopausal women with early breast cancer, adjuvant therapy with the luteinizing hormone-releasing hormone agonist goserelin (Zoladex, AstraZeneca) decreases the long-term ...